Trade Debtors Changement Date
ALKERMES USD 340.46M 5.98M 2023-09
Alnylam Pharmaceuticals USD 327.79M 2.34M 2023-12
Amarin USD 122.4M 330K 2023-09
ANI Pharmaceuticals USD 162.08M 16.76M 2023-12
Arrowhead Research USD 1.25M 68.19M 2023-06
Eisai JPY 191.91B 2.7B 2023-09
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 42.62M 1.82M 2023-09
GlaxoSmithKline GBP 8.87B 1.78B 2023-09
Heron Therapeutics USD 63.79M 12.9M 2023-09
Insmed USD 41.19M 5.61M 2023-12
Ligand Pharmaceuticals USD 39.31M 3.31M 2023-12
Merck USD 11.49B 263M 2023-09
Nektar Therapeutics USD 2.2M 869K 2023-09
Neurocrine Biosciences USD 417.8M 30.2M 2023-09
Omeros USD 36.11M 4.17M 2023-09
Pacira USD 105.56M 8.6M 2023-12
Regeneron Pharmaceuticals USD 5.67B 82.8M 2023-12
Roche Holding CHF 11.36B 560M 2023-06
Surmodics USD 18.65M 1.61M 2023-09
Ultragenyx Pharmaceutical USD 79.26M 8.74M 2023-09
Veracyte USD 40.38M 1.08M 2023-12
Vertex Pharmaceuticals USD 1.54B 17.5M 2023-09



Heron Therapeutics Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.